CN102861268A - Traditional Chinese medicine for treating rheumatoid arthritis - Google Patents
Traditional Chinese medicine for treating rheumatoid arthritis Download PDFInfo
- Publication number
- CN102861268A CN102861268A CN 201110190686 CN201110190686A CN102861268A CN 102861268 A CN102861268 A CN 102861268A CN 201110190686 CN201110190686 CN 201110190686 CN 201110190686 A CN201110190686 A CN 201110190686A CN 102861268 A CN102861268 A CN 102861268A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- treatment
- caulis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine for treating rheumatoid arthritis, which consists of 40 to 50 parts of honeysuckle flower, 40 to 50 parts of dandelion, 40 to 50 parts of gypsum, 25 to 35 parts of gentiana scabra, 25 to 35 parts of glabrous greenbrier rhizome, 25 to 35 parts of giant knotweed rhizome, 10 to 20 parts of unprocessed rehmannia root, 10 to 20 parts of akebia stem, 10 to 20 parts of peony root, 10 to 20 parts of blazed leech, 15 to 20 parts of medicinal cyathula root, 5 to 15 parts of doubleteeth pubescent angelica root, 10 to 20 parts of manyprickle acanthopanax root, 5 to 10 parts of cibot rhizome and 5 to 10 parts of sargentgloryvine stem. The traditional Chinese medicine has the advantages that all the active ingredients of the preparation are Chinese herbal medicines, and the synergy of the components is reasonable; and the traditional Chinese medicine can clear heat, remove toxicity, remove dampness, dredge channel blockade, regulate the microcirculatory system, activate the channels and the meridians, promote angiotelectasis and enhance human immunity, thus achieving the purpose of treating rheumatoid arthritis.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine of the treatment rheumatic arthritis for preparing take Chinese herbal medicine as raw material.
Background technology
Rheumatic arthritis is commonly encountered diseases and frequently-occurring disease.Its main clinical characteristics is arthralgia, heating, and the joint joint stuffiness, morning is stiff, joint deformity, serious harm patient's physical and mental health.For a long time, how curing the large problem that rheumatic arthritis becomes current medical domain, is one of disease of domestic and international osteopathia field primary study control.
Chinese medicine thinks, rheumatic arthritis belongs to " arthromyodynia " category, and is how not enough by the human righteousness, experience wind, cold, wet, hot heresy and form with muscle, muscles and bones, the pain that joint etc. are located, swelling, miserable, numbness are the disease of principal character.Doctor trained in Western medicine not yet is finalized the definite cause of disease of primary disease, autoimmune is arranged, the multiple theories such as the infection of A group beta hemolytic streptococcus, viral infection, heredity, toxin, the not specific medicine for the treatment of power one side, first-selected non-deep and remote body anti-inflammatory agent, but only be symptomatic treatment, and any Therapeutic Method no matter, can not be effectively same to each patient, can not be effective to each period of same position patient.
The Chinese medicine scholar is inheriting on forefathers' the basis in recent years, and the etiology and pathogenesis research of rheumatic arthritis has been obtained many achievements, should disease also accumulate certain experiences with Chinese medicine, and found Chinese medicinal formulae and the treatment Fang Yifa of some determined curative effects.Treatment by Chinese herbs primary disease effect is remarkable, and few side effects share toxic and side effects, reduction relapse rate, the curative effect that increases that can reduce Western medicine and bring with Western medicine.
Although the Chinese patent medicine kind of existing multiple treatment rheumatic arthritis is for selection of clinical at present, but because the market demand of rheumatic arthritis medicine is very large, and western medicine primary disease curative effect is undesirable, and side effect is more, though existing Chinese patent medicine kind is many, but most curative effects are little very desirable, and this provides huge market for the treatment rheumatic arthritis Chinese patent medicine preparation of researching and developing new determined curative effect.
In addition, the Chinese medicine formula that many description treatment rheumatic arthritis are arranged in the Chinese patent, but these prescriptions or fill a prescription unreasonable, uncertain therapeutic efficacy is cut, expensive, preparation is complicated, also has no the report that these prescriptions produce good result in actual applications simultaneously, and particularly some prescriptions have no to be committed at all and produce or market sale.
Summary of the invention
The objective of the invention is to overcome the deficiencies in the prior art, a kind of Chinese medicine of the treatment rheumatic arthritis for preparing take Chinese herbal medicine as raw material is provided.
Technical scheme of the present invention is:
A kind of Chinese medicine of the treatment rheumatic arthritis for preparing take Chinese herbal medicine as raw material, this medicine is to be made by the raw material of following weight portion proportioning:
A kind of Chinese medicine for the treatment of rheumatic arthritis is characterized in that it is to be made by the raw material of Chinese medicine of following weight proportion:
Flos Lonicerae 40-50 part, Herba Taraxaci 40-50 part, Gypsum Fibrosum 40-50 part, Radix Gentianae 25-35 part, Rhizoma Smilacis Glabrae 25-35 part, Rhizoma Polygoni Cuspidati 25-35 part, Radix Rehmanniae 10-20 part, Caulis Akebiae 10-20 part, Radix Paeoniae Rubra 10-20 part, process Hirudo 10-20 part, Radix Cyathulae 15-20 part, Radix Angelicae Pubescentis 5-15 part, Radix Et Caulis Acanthopanacis Senticosi 10-20 part, Rhizoma Cibotii 5-10 part, Caulis Sargentodoxae 5-10 part.
Its preferred weight proportioning is:
45 parts of Flos Loniceraes, 40 parts of Herba Taraxacis, 40 parts of Gypsum Fibrosum, 30 parts of Radix Gentianaes, 30 parts of Rhizoma Smilacis Glabraes, 25 parts of Rhizoma Polygoni Cuspidati, 15 parts in the Radix Rehmanniae, 10 parts of Caulis Akebiaes, 15 parts of Radix Paeoniae Rubra are processed 10 parts of Hirudos, 15 parts of Radix Cyathulaes, 10 parts of Radix Angelicae Pubescentiss, 15 parts of Radix Et Caulis Acanthopanacis Senticosis, 7 parts of Rhizoma Cibotii, 6 parts of Caulis Sargentodoxae.
Described a kind of preparation method for the treatment of the Chinese medicine of rheumatic arthritis is characterized in that: described Chinese medicine is to be prepared into pill or powder or tablet or capsule dress powder according to the conventional technology of preparing of Chinese medicine.
Beneficial effect of the present invention is mainly reflected in:
The active ingredient of preparation of the present invention all is Chinese herbal medicine, and the component compatibility is reasonable.It regulates microcirculqtory system with heat-clearing and toxic substances removing, removing dampness and dredging channel blockade, gets through the footpath arteries and veins, promotes telangiectasis, improves immune function of human body, thereby reach the purpose for the treatment of rheumatism joint inflammation.
The specific embodiment
The invention will be further described below in conjunction with specific embodiment, but do not limit the present invention.
Embodiment 1
With decoction treating rheumatic arthritis disease.Get 45 parts of Flos Loniceraes, 40 parts of Herba Taraxacis, 40 parts of Gypsum Fibrosum, 30 parts of Radix Gentianaes, 30 parts of Rhizoma Smilacis Glabraes, 25 parts of Rhizoma Polygoni Cuspidati, 15 parts in the Radix Rehmanniae, 10 parts of Caulis Akebiaes, 15 parts of Radix Paeoniae Rubra, process 10 parts of Hirudos, 6 parts of 15 parts of Radix Cyathulaes, 10 parts of Radix Angelicae Pubescentiss, 15 parts of Radix Et Caulis Acanthopanacis Senticosis, 7 parts of Rhizoma Cibotii, Caulis Sargentodoxae are prepared into said medicine and decoction day take liquid according to existing decoction preparation production technology regulation, the patient took by the course for the treatment of, and per 10 days is a course for the treatment of, serve on 6 courses for the treatment of, namely heal.
Embodiment 2
With pill treatment rheumatism joint inflammation.Get 50 parts of Flos Loniceraes, 45 parts of Herba Taraxacis, 45 parts of Gypsum Fibrosum, 30 parts of Radix Gentianaes, 25 parts of Rhizoma Smilacis Glabraes, 30 parts of Rhizoma Polygoni Cuspidati, 10 parts in the Radix Rehmanniae, 15 parts of Caulis Akebiaes, 10 parts of Radix Paeoniae Rubra are processed 15 parts of Hirudos, 20 parts of Radix Cyathulaes, 8 parts of Radix Angelicae Pubescentiss, 15 parts of Radix Et Caulis Acanthopanacis Senticosis, 6 parts of Rhizoma Cibotii, 8 parts of Caulis Sargentodoxae.The said medicine component is respectively become pill according to existing preparation pill technical regulation system, per 96 grams.The patient took by the course for the treatment of, and per 10 days is a course for the treatment of, serve on 6 courses for the treatment of three times every day, namely healed.
Embodiment 3
With powder treatment rheumatism joint inflammation.Get 40 parts of Flos Loniceraes, 45 parts of Herba Taraxacis, 45 parts of Gypsum Fibrosum, 30 parts of Radix Gentianaes, 35 parts of Rhizoma Smilacis Glabraes, 30 parts of Rhizoma Polygoni Cuspidati, 15 parts in the Radix Rehmanniae, 10 parts of Caulis Akebiaes, 10 parts of Radix Paeoniae Rubra are processed 15 parts of Hirudos, 20 parts of Radix Cyathulaes, 5 parts of Radix Angelicae Pubescentiss, 20 parts of Radix Et Caulis Acanthopanacis Senticosis, 5 parts of Rhizoma Cibotii, 5 parts of Caulis Sargentodoxae.Above-mentioned Chinese medicine component is prepared into powder according to existing preparation powder technical regulation.The patient took by the course for the treatment of, serve on 6 courses for the treatment of per 10 courses for the treatment of greatly every day three times, namely healed.
Embodiment 4
With tablet in treatment rheumatism joint inflammation.Get 42 parts of Flos Loniceraes, 40 parts of Herba Taraxacis, 48 parts of Gypsum Fibrosum, 32 parts of Radix Gentianaes, 32 parts of Rhizoma Smilacis Glabraes, 27 parts of Rhizoma Polygoni Cuspidati, 12 parts in the Radix Rehmanniae, 12 parts of Caulis Akebiaes, 17 parts of Radix Paeoniae Rubra are processed 16 parts of Hirudos, 15 parts of Radix Cyathulaes, 8 parts of Radix Angelicae Pubescentiss, 15 parts of Radix Et Caulis Acanthopanacis Senticosis, 7 parts of Rhizoma Cibotii, 6 parts of Caulis Sargentodoxae.Above-mentioned Chinese medicine component is prepared into tablet according to existing preparation tablet technical regulation.The patient took by the course for the treatment of, and per 10 days is a course for the treatment of, and the pasture twice-daily serve on 6 courses for the treatment of, namely heals.
Embodiment 5
With capsule dress powder treatment rheumatism joint inflammation.Get 47 parts of Flos Loniceraes, 46 parts of Herba Taraxacis, 43 parts of Gypsum Fibrosum, 26 parts of Radix Gentianaes, 31 parts of Rhizoma Smilacis Glabraes, 35 parts of Rhizoma Polygoni Cuspidati, 16 parts in the Radix Rehmanniae, 15 parts of Caulis Akebiaes, 15 parts of Radix Paeoniae Rubra, process 10 parts of Hirudos, 7 parts of 15 parts of Radix Cyathulaes, 5 parts of Radix Angelicae Pubescentiss, 13 parts of Radix Et Caulis Acanthopanacis Senticosis, 5 parts of Rhizoma Cibotii, Caulis Sargentodoxae are prepared from the technical regulation of above-mentioned Chinese medicine component according to existing preparation pill capsule dress powder dosage form.The patient took by the course for the treatment of, and per 10 days is a course for the treatment of, serve on 6 courses for the treatment of three times every day, namely healed.
Claims (3)
1. Chinese medicine for the treatment of rheumatic arthritis, it is characterized in that it is to be made by the raw material of Chinese medicine of following weight proportion: Flos Lonicerae 40-50 part, Herba Taraxaci 40-50 part, Gypsum Fibrosum 40-50 part, Radix Gentianae 25-35 part, Rhizoma Smilacis Glabrae 25-35 part, Rhizoma Polygoni Cuspidati 25-35 part, Radix Rehmanniae 10-20 part, Caulis Akebiae 10-20 part, Radix Paeoniae Rubra 10-20 part is processed Hirudo 10-20 part, Radix Cyathulae 15-20 part, Radix Angelicae Pubescentis 5-15 part, Radix Et Caulis Acanthopanacis Senticosi 10-20 part, Rhizoma Cibotii 5-10 part, Caulis Sargentodoxae 5-10 part.
2. a kind of Chinese medicine for the treatment of rheumatic arthritis according to claim 1, it is characterized in that: it is to be made by the raw material of Chinese medicine of following weight proportion:
45 parts of Flos Loniceraes, 40 parts of Herba Taraxacis, 40 parts of Gypsum Fibrosum, 30 parts of Radix Gentianaes, 30 parts of Rhizoma Smilacis Glabraes, 25 parts of Rhizoma Polygoni Cuspidati, 15 parts in the Radix Rehmanniae, 10 parts of Caulis Akebiaes, 15 parts of Radix Paeoniae Rubra are processed 10 parts of Hirudos, 15 parts of Radix Cyathulaes, 10 parts of Radix Angelicae Pubescentiss, 15 parts of Radix Et Caulis Acanthopanacis Senticosis, 7 parts of Rhizoma Cibotii, 6 parts of Caulis Sargentodoxae
3. the Chinese medicine for the treatment of rheumatic arthritis according to claim 1 is characterized in that described Chinese medicine is to be prepared into pill or powder or tablet or capsule dress powder according to the conventional technology of preparing of Chinese medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110190686 CN102861268A (en) | 2011-07-08 | 2011-07-08 | Traditional Chinese medicine for treating rheumatoid arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110190686 CN102861268A (en) | 2011-07-08 | 2011-07-08 | Traditional Chinese medicine for treating rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102861268A true CN102861268A (en) | 2013-01-09 |
Family
ID=47440583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110190686 Pending CN102861268A (en) | 2011-07-08 | 2011-07-08 | Traditional Chinese medicine for treating rheumatoid arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102861268A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257991A (en) * | 2014-10-08 | 2015-01-07 | 赵龙山 | Traditional Chinese medicine liquid for treating rheumatic arthritis |
| JP2016088939A (en) * | 2014-11-06 | 2016-05-23 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Composition for promoting generation of hyaluronic acid containing dandelion extract, and use thereof |
-
2011
- 2011-07-08 CN CN 201110190686 patent/CN102861268A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257991A (en) * | 2014-10-08 | 2015-01-07 | 赵龙山 | Traditional Chinese medicine liquid for treating rheumatic arthritis |
| JP2016088939A (en) * | 2014-11-06 | 2016-05-23 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Composition for promoting generation of hyaluronic acid containing dandelion extract, and use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101129594A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN101138614A (en) | Chinese traditional medicine for treating exogenous fever | |
| CN101897879B (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN101152335A (en) | Traditional Chinese medicine for treating acute gingivitis | |
| CN101152354A (en) | Traditional Chinese medicine for treating acute dacryocystitis | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN101152453A (en) | Traditional Chinese medicine for treating chronic gingivitis | |
| CN103550479B (en) | A kind of topical composition for the treatment of rheumatalgia | |
| CN102861268A (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
| CN102225118B (en) | Blood-activating wind-dispelling liquid | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN104027514A (en) | Traditional Chinese medicine used for treating acute cholecystitis | |
| CN1325096C (en) | Chinese medicine formulation for treating ance disease | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN103784824A (en) | Chinese herbal preparation for treating lumbar disc herniation and rheumatoid | |
| CN103893502A (en) | Traditional Chinese medicine for treating phlyctenular conjunctivitis | |
| CN102078432A (en) | Medicament for treating skin itch | |
| CN101095810B (en) | Decoction medicine for treating seborrhoeic dermatitis and method for preparing the same | |
| CN101904997A (en) | Formula of traditional Chinese medicine for treating appendicitis | |
| CN101129742A (en) | Traditional Chinese medicine for treating rheumatoid arthritis in active stage | |
| CN103989771A (en) | Pearl powder scald ointment | |
| CN103479815A (en) | Traditional Chinese medicine for treating urinary tract infection | |
| CN102743524B (en) | Traditional Chinese medicine for treating rheumatism | |
| CN103372187A (en) | Medicine for treating urticaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130109 |